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Abstract
Introduction. Over time, endovascular techniques of abdominal aortic aneurysm repair became the principal 
methods of treatment of this potentially fatal disease. Currently, endovascular aneurysm repair (EVAR) consti-
tutes an effective alternative to open surgery, also in cases of aneurysm rupture. Low degree of invasiveness is 
the main advantage of this method. Introduction of a system enabling percutaneous stent-graft implantation 
appears to be the next step in the development of endovascular AAA surgery. 
Aim of the study is to evaluate the Prostar XL® closure device with regard to clinical effectiveness, safety, 
cost-effectiveness. 
Material and methods. The study included 100 patients (from January 2013 to December 2015) subject 
to endovascular abdominal aortic aneurysm repair in the infrarenal region of the aorta with the application of 
the Prostar Xl® closure device. Most patients were operated under epidural anaesthesia. Local anaesthesia (1% 
Lidocaine) was used in 36 patients due to comorbidities. A possible application of the closure system depended 
on a preoperative assessment of common femoral arteries using ultrasonography. Presence of atherosclerotic 
plaque on the anterior wall of the vessel disqualified the patient from percutaneous endovascular aneurysm 
repair (PEVAR). The main part of the procedure consisted of stent-graft implantation into the abdominal aortic 
aneurysm. In the final stage, puncture site on the anterior wall of common femoral arteries was closed using 
previously placed sutures of the Prostar XL system. The wound in the inguinal region was closed with a skin suture. 
Results. The analysis of obtained results demonstrated significantly shorter mean hospitalization times in 
patients treated with PEVAR compared to EVAR. Low rates and types of observed complications in the study 
group (PEVAR) compared to the control group (EVAR) are strongly in favour the percutaneous technique 
(PEVAR) of endovascular aortic abdominal aneurysm repair in the infrarenal region of the aorta, confirming its 
minimally invasive character. 
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Introduction 
Over time, the endovascular technique of abdom­
inal aortic aneurysm repair developed by Volodos in 
the 1980s and Parodi in the 1990s became a principal 
method of treatment of this potentially fatal disea­
se [1]. Currently, endovascular procedure (EVAR) 
became an effective alternative to open surgery, also 
in cases of ruptured aneurysms [2–4]. Low degree of 
invasiveness, which is the basic safety requirement for 
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the procedure in patients with cardiovascular comor­
bidities, constitutes the main advantage of this method. 
Implementation of a system enabling percutaneous 
stent­graft implantation seems to be the next step in 
the development of endovascular surgery. Inadequate 
experience of the operating surgeon and lack of prop­
erly equipped hybrid cath lab are the natural limitations 
of endovascular procedures, EVAR in particular. Rapidly 
growing number of procedures performed using EVAR 
technique opened a new chapter in the history of 
vascular surgery. It was also an inspiration for further 
progress and simplification of procedures, increasing 
their accessibility. Reduced hospitalization time, lower 
costs of treatment and, above all, the significantly less 
invasive character of this procedure are strong enough 
reasons for routine use of EVAR together with Prostar 
XL system. 
Authors of this study aimed to evaluate the Prostar 
XL® system based on 100 cases of percutaneous AAA 
repair with regard to the following categories: technical 
success — expressed as the proportion of conversions 
to classic closure of anterior wall of the common fem­
oral artery due to suture leakage to the total number 
of performed procedures, safety of the closure system 
— defined as the number and quality of complications 
associated with the use of Prostar XL and ability to treat 
them in a fast and effective manner, as well as cost-ef­
fectiveness — defined as hospitalization time and total 
cost of the procedure. In order to validate the study, we 
compared obtained results to a control group of equal 
size, consisting of 100 patients undergoing EVAR with 
surgical exposure of femoral arteries. 
Material and methods
There were 432 patients treated surgically 
for an abdominal aortic aneurysm at our Depart­
ment between January 2013 and December 2015. 
The study included 100 patients treated with percuta­
neous stent­graft implantation using the Prostar XL® 
system. Each patient was referred for endovascular 
treatment of AAA based on angio­CT imaging. Patients 
also underwent an ultrasound examination of the com­
mon femoral arteries. Authors of this study support 
the notion that computed tomography angiography, 
which is the basis of qualification to endovascular AAA 
repair, should also involve the evaluation of common 
femoral arteries. Presence of atherosclerotic plaque 
on the anterior wall of the vessel (from the level of 
inguinal ligament to the bifurcation) in both CT and 
Doppler ultrasound ruled out possible application of the 
Prostar XL® system. Figure 1 and 2 show an ultrasound 
picture of a vessel that precludes the potential use of 
the Prostar XL closure system. However, tortuous 
inguinal arteries did not constitute contraindications 
to Prostar XL. The procedure was performed under 
conditions typical for any other endovascular surgery, 
using standard disinfecting agents and usual draping of 
the surgical field. Epidural anesthesia was used during 
the procedure. Local anesthesia using 1% Lidocaine 
(about 15 mL for each side) was used in about 31 cases 
due to comorbidities. Among the entire group of 162 
subjects, 41 patients underwent urgent surgery for a 
symptomatic abdominal aortic aneurysm. Remaining 
patients were treated with elective procedures. Table 1 
presents the numerical distribution of the study group. 
Control group consisted of 100 patients treated with 
stent­graft implantation to AAA through classic surgical 
exposure of common femoral arteries. Demographic 
characteristics of both groups are presented in Table 1. 
Figure 1. Atherosclerotic plaque at the anterior wall of com­
mon femoral artery
Figure 2. Anterior wall of common femoral artery without 
atherosclerotic lesions
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Under ultrasound guidance, the anterior wall of 
the femoral artery was punctured with an 18G needle 
at a 45o angle to the long axis of the vessel (common 
femoral artery). The system was introduced along with 
a 180-cm hydrophilic Terumo® guidewire. Tissues were 
separated to create a channel to the anterior arterial 
wall, enabling uninterrupted tightening of sutures at 
the final stage of the procedure. Proper positioning of 
the effector part of the system (in the arterial lumen) 
was indicated by retrograde blood flow from a control 
cannula running from the top of the effector part of 
the system to its “handle”. In the next step, sutures 
were placed according to the method designed for 
the Prostar XL® system. The contralateral femoral 
procedure was prepared in an analogous manner. Each 
patient routinely received 5 thousand units of unfrac­
tionated heparin intraoperatively. The main part of the 
procedure involved implantation of a stent­graft into the 
abdominal aortic aneurysm using a surgical technique 
recommended for an individual type of endograft. At the 
final stage, the opening in the anterior wall of the com­
mon femoral artery (formed due to the introduction of 
the stent-graft system) was closed by tightening of the 
previously placed sutures using a “Knot Pusher” includ­
ed in a standard Prostar XL® set. Tissue channel (about 
10 mm in diameter) formed, as previously mentioned, 
by incising the skin in the axis of the system and sepa­
rating tissues around the cannula, ran from skin surface 
down to the wall of the artery, enabling uninterrupted 
placement of sutures in the desired location (anterior 
wall of common femoral artery). The procedure was 
finished with the placement of single skin sutures at the 
puncture site in the inguinal region bilaterally (Fig. 3). 
Among the aforementioned group of 31 patients, the 
puncture site was anesthetized on both sides in the 
first stage of the procedure and the remaining steps of 
PEVAR were conducted in a manner analogous to that 
described above. A protocol of follow-up visits was 
established for the study group: 4 weeks, 12 weeks, 
6 months, and 12 months after surgery. Ultrasound 
examination of the puncture site (inguinal regions bilat­
erally), common femoral veins, stent-graft positioning, 
blood flow through the main body of the stent-graft as 
well as through its inguinal extensions was performed 
in each patient four weeks after the procedure. Similar 
assessments were performed during follow-up visits 12 
weeks and 6 months after the procedure. During the 
1-year follow-up visit patients underwent angio-CT 
examination, enabling detection of a possible leak. Each 
patient received double antiplatelet therapy postoper­
atively, which was reduced to ASA only starting from 
the 6th month after the procedure. 
Analysis of results
The analysis included 100 patients treated with 
percutaneous endovascular aneurysm repair (PEVAR) 
method using a Prostar XL® closure system. Obtained 
numerical results were subject to a comparative anal­
ysis between the study group and the control group 
comprising of 100 patients treated with standard EVAR 
technique with regard to three categories: 1) technical 
success of Prostar XL closure system — was obtained 
in 95 cases from the study group, amounting to 95% of 
subjects. Among 6 complications, which amounted to 
3.7% of the study group, bleeding at the site of Prostar 
XL suture placement was observed in 4 cases and in 
2 cases pseudoaneurysms were diagnosed after three 
and six months of follow-up. In the control group (100 
Table 1. Comparison of study group (PEVAR) and control group (EVAR) hospitalization times
Patient  
group
Sex No. Mean  
age
Mean hospitalization 
time 
K/M days
Mean hospitalization 
time/total 
(days)
Difference 
Days/% 
(M)
Difference 
Days/% 
(K)
Difference 
Total 
Days/%
Study  
group
F 22 74.77 2.36 2.45 2.38  
d/49.07%
2.59 
d/53.40%
2.42 
d/49.69%
M 78 75.47 2.47 
Control 
group
F 20 71.40 4.95 4.87
M 80 72.70 4.85
Figure 3. Cosmetic effect of the PEVAR procedure using 
Prostar XL
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patients) complications were noted in 5 cases, which 
amounted to 5% of the control group. Complications 
included two cases of lymphorrhea at the surgical 
site, two cases of wound infection, and one case of 
hematoma at the surgical site. Numerical distributions 
of observed complications are presented in Table 2. 
2) safety of the Prostar XL closure system was assessed 
in relation to the types of observed complications. As 
mentioned before, pseudoaneurysm in the inguinal 
region was diagnosed in 2 cases. The smaller one (21 × 
32 mm) was treated successfully with Thrombin 400® 
injection under ultrasound guidance (Figs 1, 2), while the 
larger one was removed surgically. In four cases bleeding 
at the site of Prostar XL, suture placement was man­
aged intraoperatively by converting to open procedure 
— a common femoral artery was exposed at the pun- 
cture site and the opening in the wall was closed 
with Prolene 5-0 continuous suture. Such a conduct is 
a part of routine training for a vascular surgeon and does 
not pose a particular challenge. 3) Cost-effectiveness was 
assessed by comparing the duration of hospitalization and 
total cost of treatment between study and control groups. 
Comparative analysis demonstrated that hospitalization 
time was significantly shorter after PEVAR compared to 
EVAR and amounted to 2.45 days. Table 1. compares 
hospitalization times in the compared patient groups.
Discussion 
Percutaneous implantation of a stent­graft into ab­
dominal aortic aneurysm appears to be a natural step 
in the development of minimally invasive endovascular 
techniques [5, 6]. It is particularly important for patients 
with multiple comorbidities, especially cardiological, in 
whom a standard EVAR procedure performed under 
epidural anaesthesia constitutes an elevated surgical 
risk [4, 7, 8]. Literature underscores the importance of 
proper classification of patients for PEVAR procedure, 
which determines the technical success of the surgery. 
Presence of severe atherosclerotic lesions involving 
common femoral artery is a fundamental contraindi­
cation for percutaneous stent-graft implantation [9] 
point to the prognostic value of atherosclerotic plaque 
at the anterior wall of CFA, but do not postulate it as 
an absolute contraindication to PEVAR on that basis. In 
our opinion, identification of atherosclerotic lesions in 
this location at the CFA wall constitutes a contraindica­
tion to PEVAR. Angio-CT examination (encompassing 
common femoral arteries) is somewhat helpful in the 
qualification to the percutaneous procedure, enabling 
proper preoperative assessment of the anatomy of the 
aorta, inguinal and femoral arteries [10]. Obese patients 
(BMI > 30) constitute a special group of patients with 
a particularly high surgical risk, particularly with respect Ta
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to open procedures [11]. A decision regarding the choice 
of proper surgical technique should take into consideration 
PEVAR as first-line treatment of AAA repair being least 
burdensome. We share this belief. Among our study group, 
12 patients were obese, including 9 with BMI between 
30 and 40 kg/m2 and 3 with BMI over 40 kg/m2. In this group 
PEVAR procedures were complication-free, supporting 
the rationale for qualifying obese patients to the percuta­
neous procedure. The problem of qualifying patients with 
BMI over 30 is often a matter of discussion in numerous 
reports, wherein particular emphasis is put on the value 
of minimally invasive procedures, such as PEVAR [3]. 
Complications associated with the use of Prostar XL 
closure systems observed in this study are partly justified 
by the relatively limited experience of the operating 
surgeon as well as improper patient qualification to the 
procedure. In a retrospective analysis of 2381 cases of 
percutaneous stent-graft implantation to AAA, Pratesi G, 
Barbante underscore the importance of proper training, 
which requires at least 50 PEVAR procedures performed 
independently [8, 12]. Presumably, any minimally invasive 
procedure is meant for patients with a particularly high 
risk of periprocedural complications due to multiple 
comorbidities, especially cardiological [13]. As previously 
mentioned in the paragraph describing the study group, 
only local anesthesia could be used in 31 of 100 patients. 
The procedure itself as well as the postoperative period 
was unremarkable, which strengthens our conviction 
that local analgesia could be used in patients with other 
comorbidities that increase the risk of complications. 
Similar conclusions may be found in numerous publications 
concerning the choice of proper anesthesia for severely ill 
patients referred for EVAR [14]. There are some doubts 
with regard to the quality of intraoperative imaging, es­
pecially at critical moments when precise stent expansion 
is a priority (stent-graft positioning), in the presence of 
unintended patient moves [15]. Our experiences do not 
corroborate the above­mentioned concerns. 
CONCLUSIONS
 Based on the analysis of our results, we concluded 
as follows:
1. The use of the Prostar XL closure system for end­
ovascular AAA repair appears to be rational and 
highly beneficial. 
2. The types of observed complications allowing for 
simple intraoperative management point to a high 
degree of safety. 
3. Minimal invasiveness of the procedure and possi­
ble use of local anaesthesia enable the use of this 
method even in patients with significant cardiological 
comorbidities. 
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